 Four months later, two other protease inhibitors, ritonavir and indinavir, were approved.In 2009, ten protease inhibitors have reached the market for treatment against HIV but one protease inhibitor, amprenavir, was withdrawn from the market in 2004.HIV belongs to the class of viruses called retroviruses, which carry genetic information in the form of RNA.